Allscripts Continues to Lead in Interoperability, Driving Successful Healthcare Delivery

AllscriptsAllscripts (NASDAQ: MDRX) remains committed to effective interoperability in healthcare delivery. A leader in interoperability and open platforms, the company has made it a priority to deliver clinicians accessible, clinically relevant information at the point of care, creating a community patient record and enabling successful care delivery.

Allscripts dbMotion™ Solution has been delivering clinically relevant, meaningful interoperability for many years. With dbMotion, which enables the sharing of data across different EHR systems regardless of vendor, clinicians can engage their care teams and improve access to real-time, harmonized information from across the care continuum. Used around the world in the United States, Australia, Canada, United Kingdom and Israel, the solution leverages and shares data assets, achieving safer high-quality clinical outcomes.

Every month the following volumes are enabled:

  • 14M+ unique patient transactions are received in dbMotion
  • 31,000+ providers and 128,000+ users interact with dbMotion
  • 2,700+ ambulatory and post-acute facilities transmit data with dbMotion
  • 1,000+ hospitals transmit data with dbMotion

Over the past 12 months, dbMotion has achieved significant client success with the sharing of information including:

  • 1B+ pieces of patient demographics data
  • 650M+ observation results
  • 350M+ pharmacy data
  • 289M+ documents
  • 104M+ orders (pharmacy/treatment)
  • 58M+ full patient data records

Allscripts was recently recognized as a growth and innovation top-performing leader in Frost & Sullivan’s Frost Radar™: US Healthcare Data Interoperability Market, 2020. The report states that Allscripts demonstrates superior interoperability across the entire HIT ecosystem by enabling the direct integration of third-party clinical decision support applications into the company’s platforms through on-premise or cloud deployment models.

"Allscripts has advocated for having an open platform since 2007 and we believe interoperability is the foundation for advancing healthcare - data and access should be Open. For Everyone™," said Allscripts Chief Executive Officer, Paul M. Black. "Our systems - all of them - should be able to talk to each other. Through dbMotion, we have helped providers all around the world collaborate, deliver higher-quality care, lower costs and help consumers achieve better outcomes. We are proud of the interoperability tools we offer, creating a health ecosystem where critical data is made useful by combining isolated islands of community information into a single, actionable patient record. We remain committed to assisting in successful healthcare delivery for today and tomorrow."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...